Introduction
Congenital heart defects are a leading cause of perinatal mortality and morbidity, affecting 1% of all live births in the Western world (1) . A common arterial trunk (CAT, also known as persistent truncus arteriosus) is a rare defect caused by faulty remodeling of the heart outflow tract (OFT) during embryogenesis. The OFT is a transient embryonic structure at the arterial pole of the heart that initially functions as a conduit for blood flowing from the right ventricle into the aortic sac. Subsequently, the OFT wall rotates and septates to generate the base of the ascending aorta and pulmonary trunk, which enables the separation of the arterial and venous circulation. A failure of OFT septation during embryogenesis therefore results in inappropriate mixing of oxygenated and deoxygenated blood at birth and has an unfavorable clinical prognosis (2) .
Initially, the OFT comprises a solitary tube filled with an acellular cardiac jelly of extracellular matrix components that is gradually colonized by cells from several distinct sources to form the endocardial cushions as a prerequisite for septation (3, 4) . Cushion formation and septation rely on the interaction of 3 distinct cell types, cardiac neural crest cells (NCCs), second heart field-derived (SHF-derived) cells, and endothelial cells (ECs). The immigration of cardiac NCCs into the OFT correlates with an endothelial-to-mesenchymal (endoMT) transition of OFT endothelium into mesenchymal cells that colonize the cushions (5) . Once the endocardial cushions have sufficiently expanded, the OFT endothelium fuses, starting in the distal and progressing to the proximal part of the tract, and a septal bridge is formed. SHF-derived smooth muscle cells (SMCs) from the OFT wall and myocardium enter the emerging septum to complete the septation process through myocardialization (6, 7) . Eventually, the leading edge of the muscular septum attaches to the interventricular septum, thus fusing the base of the aorta and the base of the pulmonary artery to the ventricles.
The molecular mechanisms by which cardiac NCCs, SHFderived cells, and ECs cooperate during OFT septation are partially understood. Two signaling cues essential for OFT septation are the class 3 semaphorin SEMA3C and the vascular endothelial growth factor VEGF-A. Thus, lack of OFT septation is seen in Sema3c-null mice (8) and Vegfa 120/120 mice expressing the VEGF120 isoform of VEGF-A at the expense of the larger, heparin/neuropilin-binding isoforms VEGF165 and VEGF188 (9) . However, the precise cellular mechanisms by which these ligands promote OFT remodeling are unknown.
Neuropilin 1 (NRP1) is a transmembrane receptor for both SEMA3C and VEGF165 (10) . Consistent with an essential role for NRP1 in OFT remodeling, Nrp1-null mice have CAT (11) . The finding that endothelial NRP1 is required for OFT septation in the mouse has been interpreted as evidence that it functions as a VEGF165 receptor during endothelial remodeling in the OFT (12, 13) . Yet it has not been demonstrated that VEGF-A binding to NRP1 is essential for this process. Additionally, it has been suggested that NRP1 serves as a semaphorin receptor in cardiac NCCs, where it is partially redundant with its homolog NRP2 (13, 14) . To convey semaphorin signals in cardiac NCCs, NRPs are thought to form a complex with a plexin coreceptor termed PLX-NA2, which is expressed in cardiac NCCs (15) . However, a role for
In mammals, the outflow tract (OFT) of the developing heart septates into the base of the pulmonary artery and aorta to guide deoxygenated right ventricular blood into the lungs and oxygenated left ventricular blood into the systemic circulation. Accordingly, defective OFT septation is a life-threatening condition that can occur in both syndromic and nonsyndromic congenital heart disease. Even though studies of genetic mouse models have previously revealed a requirement for VEGF-A, the class 3 semaphorin SEMA3C, and their shared receptor neuropilin 1 (NRP1) in OFT development, the precise mechanism by which these proteins orchestrate OFT septation is not yet understood. Here, we have analyzed a complementary set of ligand-specific and tissue-specific mouse mutants to show that neural crest-derived SEMA3C activates NRP1 in the OFT endothelium. Explant assays combined with gene-expression studies and lineage tracing further demonstrated that this signaling pathway promotes an endothelial-to-mesenchymal transition that supplies cells to the endocardial cushions and repositions cardiac neural crest cells (NCCs) within the OFT, 2 processes that are essential for septal bridge formation. These findings elucidate a mechanism by which NCCs cooperate with endothelial cells in the developing OFT to enable the postnatal separation of the pulmonary and systemic circulation.
and Tie2-Cre Rosa Yfp OFTs for YFP. As expected, Tie2-Cre targeted the endothelium, whereas Wnt1-Cre did not ( Figure 3A) . Instead, Wnt1-Cre-targeted cardiac NCCs contributed to the semilunar valve leaflets and septal bridge ( Figure 3A ). In the Tie2-Cre lineage-traced OFT, many individual YFP-positive cells were present in the endocardial cushions ( Figure 3A) , consistent with the previously described contribution of endoMT-derived cells to the endocardial cushions (17) (18) (19) . Tie2-Cre lineage-traced cells also contributed to the semilunar valves ( Figure 3A ). This analysis therefore confirmed the distinct contributions of EC-and cardiac NCC-derived lineages to the OFT.
NCC-derived NRP1 is not required for OFT septation in the mouse. Because a role for NRP1 in cardiac NCC migration had previously been reported in chick (14) , we investigated whether cardiac NCC-derived NRP1 is required for OFT septation in mice by comparing immunolabeled serial sections through the E12.5 OFTs of Wnt1-Cre Nrp1 fl/fl mutants and controls. Efficient targeting of NRP1 in the NCC lineage was previously demonstrated by similar defects in the NCC-derived sympathetic nervous systems of Wnt1-Cre Nrp1 fl/fl mutants and full Nrp1 knockouts (20) . However, and in contrast with Nrp1 -/-mice, the OFTs of Wnt1-Cre Nrp1 fl/fl mutants were septated normally ( Figure 3B , top panels). To address whether NRP2 compensated for the lack of NRP1 in cardiac NCCs, as previously proposed (13, 14) , we crossed Wnt1-Cre Nrp1 fl/fl mutants onto an Nrp2-null background. However, compound mutants also showed normal OFT septation, rotation, and myocardialization ( Figure 3B , middle panels). Contrary to prior hypotheses, NRP1 and NRP2 expression by cardiac NCCs is therefore not required for OFT remodeling.
Endothelial NRP1 is essential for OFT septation in the mouse. Ink injections previously demonstrated that mice lacking endothelial NRP1 (Tie2-Cre Nrp1 fl/-) have defective OFT septation (12, 13) . Using immunolabeling of serial sections, we confirmed that Tie2-Cre Nrp1 fl/-mutants had OFT defects similar to full NRP1 knockouts ( Figure 3B , bottom panels). In particular, our method demonstrated septation defects in both the proximal and distal part of mutant OFTs as well as abnormal associations between the endocardium and myocardium ( Figure 3B , bottom panels). Furthermore, Tie2-Cre Nrp1 fl/-OFTs showed failed rotation and impaired septal bridge myocardialization ( Figure 3B , bottom panels). Taken together with the analysis of NCC-specific Nrp1 mutants, these observations suggest that all essential NRP1 signaling during OFT remodeling takes place in the vascular endothelium.
VEGF-A signaling through NRPs is dispensable for OFT septation. Prior studies observed CAT in Vegfa 120/120 mice, which express VEGF120 at the expense of the longer, heparin/NRP-binding isoforms of VEGF-A (9). Together with the finding that mice lacking endothelial NRP1 display defective OFT septation, the phenotype of Vegfa 120/120 mice was previously interpreted as evidence for an essential role of VEGF-A signaling through NRP1 in OFT remodeling (13) . However, neither prior study was able to directly address the role of VEGF-A as a NRP1 ligand in OFT NRPs in cardiac NCCs has never been demonstrated directly for mammalian OFT remodeling.
Here, we have investigated OFT development in tissuespecific knockout mice to compare the requirement of NRP1 in OFT endothelium versus cardiac NCCs. We have also examined NRP1 knockin mice with mutations that selectively target VEGF-A versus SEMA3 binding to distinguish the relative contribution of both ligands to NRP1 signaling during OFT septation. This analysis revealed that NRP1 expression by cardiac NCCs and VEGF binding to NRP1 are both dispensable for OFT remodeling, even when NRP2 is additionally ablated. Instead, we found that loss of endothelial NRP1 was sufficient to recapitulate the OFT phenotype of Nrp1-null mice because NRP1 served as a receptor for SEMA3C in ECs. We further show that cardiac NCCs, contrary to prior hypotheses, do not respond to SEMA3C, but instead provide an essential source of SEMA3C. Thus, NCC-derived SEMA3C promotes endoMT via NRP1 and, indirectly, cardiac NCC relocalization within the OFT, 2 prerequisites for septal bridge formation in the proximal OFT. These findings identify a mechanism by which cardiac NCCs communicate with ECs to orchestrate OFT septation and therefore enable the separation of the arterial and pulmonary circulation for life after birth.
Results
Multiple roles for NRP1 during OFT remodeling. Ink injections into whole-mount hearts were previously used to demonstrate a lack of OFT septation in Nrp1-null mutants (11) . Because this technique does not reveal which specific aspects of OFT septation are defective, we devised a method that distinguishes several different processes critical for OFT septation. Thus, we immunolabeled serial sections through OFTs at E12.5 with the SMC marker smooth muscle α actin (SMA) and the vascular endothelial marker PECAM ( Figure 1 , A and B) to assess endocardial cushion swelling, endothelial fusion, and the invasion of smooth muscle and myocardial cells into the septal bridge (Figure 1B, top row) . This method showed that all Nrp1-null mutants lacked septation throughout the entire OFT, including its proximal and distal parts ( Figure 1B , middle row), and revealed that the endocardial cushions of mutants were abnormally oriented relative to the heart. In addition, mutant OFTs contained atypical associations between the endocardium and myocardium, causing cushion disorganization, similar to that seen in endothelial Nrp1-null mutants (12) . Nrp1-null mutants also lacked myocardialization of the septal bridge ( Figure 1B) , with SMA-positive cells appearing to stall within the endocardial cushions in peripheral positions (Figure 1 , B and C). In contrast, mice lacking NRP2 displayed normal OFT septation, OFT rotation, and myocardialization of the septal bridge ( Figure 1B, bottom row) .
Expression pattern of NRP1 during OFT remodeling. To define the NRP1 expression pattern during OFT remodeling, we immunolabeled serial sections through an E12.5 WT OFT with a validated antibody for NRP1 (16) together with SMA and the vascular endothelial marker isolectin B4 (IB4) (Figure 2, A and B ). This analysis demonstrated that NRP1 is expressed weakly on migrating SMA-positive cells and strongly on IB4-positive ECs (Figure 2, A and B) . In contrast, there was no obvious NRP1 expression within the region occupied by the postmigratory cardiac NCC population (Figure 2A ). mutants. Immunolabeling of serial sections for PECAM and SMA revealed that OFT septation, rotation, and myocardialization were normal in Nrp1
Vegfa/Vegfa mutants, even on an Nrp2-null background ( Figure 4C ), excluding compensation by NRP2. Thus, contrary to prior hypotheses, endothelial NRP1 does not act as a VEGF-A receptor during OFT septation.
SEMA3C is expressed by myocardial cuff cells and cardiac NCCs in the septal bridge. Even though SEMA3C is essential for OFT septation (8, 24) , its precise role in this process has not been determined to date. In agreement with prior findings (8, 25) , we observed Sema3c expression in the myocardial cuff that surrounds the aortic segment of the OFT from E10.5 onwards ( Figure 5A ). In addition, Sema3c was expressed in the area where cardiac NCCs were located from E11.5 onwards ( Figure 5A ). Several prior studies interpreted this expression pattern as an indication that SEMA3C attracts cardiac NCCs into the OFT (8, 14) . In contrast, other studies have speculated that Sema3c may also be expressed by cardiac NCCs themselves (25, 26) . To resolve this controversy, we performed Sema3c ISH on Wnt1-Cre Rosa Yfp OFTs and found that Sema3c was expressed in a subpopulation of the cardiac NCC lineage ( Figure  5B ). Double immunolabeling of sections from Wnt1-Cre Rosa Yfp development because a mouse mutant defective in VEGF-A binding to NRP1 was not available at the time. Moreover, the Vegfa expression pattern had not been analyzed to determine whether NCCs provide an important source of this growth factor for OFT remodeling. We therefore determined the Vegfa expression pattern and analyzed the OFTs of mice lacking VEGF-A expression in NCCs or VEGF-A binding to NRP1.
Using the established Vegfa expression reporter Vegfa Lacz (21), we observed weak Vegfa expression by the OFT endothelium and strong expression by the SHF-derived myocardial OFT cuff at E12.5 ( Figure 4A ). In contrast, Vegfa expression appeared absent from the area occupied by cardiac NCCs ( Figure 4A ). To confirm that cardiac NCCs are not a critical source of VEGF-A for OFT septation, we introduced Wnt1-Cre into mice with conditional Vegfa-null alleles (Vegfa fl/fl ) (22) . In agreement with the lack of obvious Vegfa expression in OFT NCCs, Wnt1-Cre;Vegfa fl/fl OFTs had normal septation ( Figure 4B ). These findings demonstrate that cardiac NCCs do not express VEGF-A to promote OFT septation.
To determine whether NRP1 serves as a VEGF-A receptor in OFT development, we used mice with a knockin mutation that impairs VEGF-A binding to NRP1 (23) 
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-/-compound mutants, raised the possibility that SEMA3C signals with partial redundancy through NRP1 and NRP2 in the OFT. However, prior work examined neither which specific aspects of OFT septation were defective in double mutants nor whether their defects were similar to those of Sema3c mutants. Immunolabeling of serial sections showed similar anatomical OFT defects in Nrp1
Sema/Sema Nrp2 -/-compared with Wnt1-Cre Sema3c fl/fl mutants, including a failure of proximal OFT septation, which was accompanied by the formation of disorganized endocardial cushions and impaired myocardialization ( Figure 6 , A and B). This observation is consistent with cardiac NCC-derived SEMA3C signaling through NRP1 to enable OFT septation, whereby NRP2 is able to compensate for the failure of Nrp1
Sema to bind SEMA3C. SEMA3C signaling through NRP1 is not required to regulate proliferation or apoptosis during OFT septation. Prior studies have shown that deletion of the BMP receptor ALK2 (ACVR1) or the TGF-β receptor ALK5 (TGFBR1) increases NCC apoptosis in the OFT and causes OFT defects (28, 29) . Likewise, loss of the retinoid X receptor α increases apoptosis in the endocardial cushions and compromises OFT remodeling (30) . Conversely, loss of FOX1P reduces apoptosis in the endocardial cushions and also causes OFT septation defects (31). We therefore immunolabeled OFT sections of mutants lacking NRP1 or NCC-derived SEMA3C for the apoptosis marker cleaved caspase 3 (aCAS3) (32, 33) at E11.5, prior to the stage when the OFT defect manifests itself in NRP1 mutants. Consistent with previous studies (34, 35) , we observed little apoptosis in the OFT at E11.5 (Supplemental Figure 1A and Supplemental Figure 2A ; supplemental material available online with this article; doi:10.1172/JCI79668DS1), with no significant difference in apoptosis between Nrp1-null and control OFTs (Supplemental Figure 1B ; P < 0.01). Together, these findings raised the possibility that SEMA3C, rather than attracting cardiac NCCs into the OFT, is secreted by cardiac NCCs to promote OFT septation.
Cardiac NCC-derived SEMA3C is essential for proximal OFT septation. To investigate whether cardiac NCC-derived SEMA3C is essential for OFT septation, we immunolabeled serial sections of Wnt1-Cre Sema3c fl/fl OFTs for PECAM and SMA; this analysis demonstrated that septation was defective in the proximal OFT of all mutants examined ( Figure 6A ). As observed for Nrp1-null mutants, Wnt1-Cre Sema3c fl/fl mutants showed abnormal associations between the OFT endothelium and myocardium, causing cushion disorganization ( Figure 6A ). Furthermore, SMA-positive cells failed to invade the septal bridge; instead, they appeared to stall within the endocardial cushions in the lateral OFT ( Previous observations that SEMA3C binds both NRP1 and NRP2 (27) and that OFT septation occurs normally in Nrp2 -/-mutants or Defects in proliferation may also cause OFT defects. Thus, deletion of the BMP type 1 receptor in NCCs reduces proliferation in the endocardial cushions and correlates with defective OFT remodeling (36) . We therefore used the proliferation marker phosphohistone H3 (pHH3) (37, 38) to label E11.5 OFT sections of Nrp1-null mutants and their littermates (Supplemental Figure  1C) , but found no significant difference (Supplemental Figure 1D ; pHH3-positive cells per OFT section: 13.5% ± 3.54% Nrp1 +/+ versus 12.88% ± 1.24% Nrp1 -/-). There was also no significant difference in the number of proliferating cells between Wnt1-Cre Sema3c ).
NRP1 is not required for cardiac NCC migration into the OFT.
The surprising lack of OFT defects in Wnt1-Cre Nrp1 fl/fl mutants ( Figure 3B ) prompted us to investigate in more detail whether NRP1 is required for cardiac NCC migration into the mouse OFT, as reported for chick (14) . X-gal staining of E10.5 OFTs containing the NCC reporter Wnt1-Cre Rosa Lacz (39) showed that cardiac NCCs migrated through the pharyngeal arch arteries and into the OFT in 2 prong-shaped streams in both Nrp1-null mutant and control OFTs (Figure 7A) . Furthermore, YFP immunostaining of serial sections through E10.5 WT OFTs carrying the Wnt1-Cre Rosa Yfp reporter showed that cardiac NCCs had populated the OFT at this stage, with a similar pattern in stage-matched Nrp1-null mutants ( Figure 7B ). Quantitation of YFP-positive cells confirmed that a similar number of cardiac NCCs had populated the OFT in both genotypes ( Figure 7C ; YFP + cells relative to control: Nrp1 +/+ 100% ± 12.2% versus Nrp1 -/-104.3% ± 25.3%). These findings imply that the OFT defect of Nrp1 -/-mutants is not caused by impaired cardiac NCC migration into the OFT.
SEMA3C signaling through NRP1 promotes NCC-dependent septal bridge formation. Because immunolabeling had shown that PLXNA2 visualizes SEMA3C-expressing cardiac NCCs ( Figure 5B), we used this marker to examine cardiac NCC behavior in NRP1 and SEMA3C mutants. PLXNA2-labeled sections through E12.5 WT OFTs confirmed that cardiac NCCs were localized in the OFT center at this stage ( Figure 8A) . Moreover, the entry of cardiac NCCs into the septal bridge appeared to precede the invasion of SMA-positive cells from the myocardial cuff into this area, whereby the invading SMA-positive cells seemed to orient themselves toward the cardiac NCCs ( Figure 8A ). These findings suggest a role for cardiac NCCs in attracting SMA-positive cells into the bridge area to initiate the process of myocardialization.
PLXNA2 immunostaining of full and endothelial-specific Nrp1 mutants showed that cardiac NCCs had reached the OFT at E12.5 ( Figure 8A ). This observation agreed with the Wnt1-Cre lineage trace at E10.5, which had demonstrated that NRP1 expression by cardiac NCCs was not required to attract these cells into the OFT (Figure 7) . Interestingly, however, PLXNA2-positive NCCs were localized in 2 lateral columns both in full and endothelial Nrp1-null OFTs at E12.5, rather than fusing in a central position as seen in WT at this stage ( Figure 8A ). The bilateral location of cardiac NCCs in mutants corresponded to the position of the 2 NCC prongs seen at E10.5 ( Figure 7A ), indicating a failure of NCC translocation to the central area. In addition, full and endothelialspecific Nrp1 mutants showed defective SMA-positive cell migration, whereby these cells were no longer oriented toward the central area of the OFT; instead, they seemed to be attracted by the mispositioned NCCs ( Figure 8A ).
The findings above are consistent with the idea that NRP1 is dispensable for cardiac NCC attraction into the OFT, but instead NRP1 is required to initiate NCC relocalization from a lateral area into a central OFT position and the ensuing attraction of SMA-positive cells into this area for septal bridge formation. In agreement with this model and demonstrating that the NRP1 ligand directing cardiac NCC translocation is SEMA3C rather than VEGF-A, NCC migration into the central OFT was normal in Nrp1
Vegfa/Vegfa Nrp2 -/-mice lacking VEGF-A signaling through NRPs, but absent in Nrp1 Sema/Sema
Nrp2
-/-mice lacking semaphorin signaling through NRPs ( Figure  8A , bottom row). Moreover, mice lacking NCC-derived SEMA3C also lacked central NCC localization, with NCCs located in 2 lateral columns and abnormal SMA-positive cell migration toward the stalled NCCs ( Figure 8A ).
To investigate how ablation of SEMA3C/NRP1 signaling in the OFT endothelium affects the behavior of the total cardiac Figure 8B ). These observations suggest that the SEMA3C-expressing cardiac NCC subset is key for septal bridge formation and the attraction of SMA-positive cells for myocardialization into the proximal OFT. Whereas NCC-derived SEMA3C was essential for cardiac NCC relocalization in the proximal OFT, cardiac NCCs had successfully migrated into the central area in the distal OFT of Wnt1-Cre Rosa Yfp Sema3c fl/fl mutants ( Figure 8B ). This observation agrees with the incomplete penetrance of septation in the distal OFT of Wnt1-Cre Sema3c fl/fl and Nrp1 Sema/Sema Nrp2 -/-mutants and suggests that factors other than NCC-derived SEMA3C can contribute to distal OFT septation (see Discussion).
Together, these findings demonstrate that semaphorin, not VEGF-A signaling through NRP1, is a major driving force underlying NCC-mediated OFT septation. Moreover, they imply that NCC-derived SEMA3C signals to endothelial NRP1 to indirectly promote cardiac NCC relocalization toward the center of the proximal OFT, which is followed by the invasion of SMA-positive cells and therefore the formation of a myocardialized septal bridge.
NCC colonization of the OFT correlates with the onset of endoMT. The results above show that mice with impaired SEMA3C/NRP1 ; P < 0.01). We also observed significantly reduced F-actin-positive outgrowth in Nrp1-null explants compared with controls ( Figure 9G ; outgrowth cells relative to control: 100% ± 5.6% Nrp1 +/+ versus 62.7% ± 5.5% Nrp1 -/-; P < 0.001). We next determined whether exogenous SEMA3C promoted endoMT in OFT explants. For this experiment, we cultured E10.5 WT OFTs for 72 hours in medium containing 1% serum and found that SEMA3C significantly promoted F-actin-positive cellular outgrowth ( Figure 9H ; percentage of outgrowth cells relative to control: 100% ± 3.9% WT versus 186% ± 25.6% WT + SEMA3C; P < 0.01). In contrast, OFT explants from Nrp1-null mutant littermates did not increase reduced F-actin-positive outgrowth in response to SEMA3C ( Figure 9I ; percentage of outgrowth cells relative to control: 100% ± 5.8% Nrp1 +/+ + SEMA3C versus 71.7% ± 15.8% Nrp1 -/-+ SEMA3C; P < 0.05). Furthermore, a direct comparison of Nrp1 -/-explants with and without SEMA3C treatment showed that F-actin-positive outgrowth in Nrp1 mutants was not affected by SEMA3C treatment (percentage of outgrowth cells relative to control: 62.7% ± 5.5% Nrp1 -/-versus 71.7% ± 15.8% Nrp1 -/-+ SEMA3C; P > 0.05). This experiment demonstrated that SEMA3C promoted F-actin-positive outgrowth in WT, but not Nrp1-null mutant explants, and suggested that cardiac NCCderived SEMA3C enhances endoMT in the OFT via NRP1.
Reduced endoMT in the OFT of mice lacking SEMA3C or NRP1 in vivo. To show that endoMT was reduced in the OFT of mice lacking NRP1 in vivo, we investigated the expression of the transcription factor Slug, a well-established effector of endoMT (42, 43) . We first performed reverse-transcription PCR (RT-PCR) analysis signaling lacking NCC-derived SEMA3C display disorganized endocardial cushions and lack proximal OFT septation, 2 processes known to rely on endoMT (17) (18) (19) . We therefore investigated whether cardiac NCC immigration and the onset of endoMT correlate during OFT development. Using Wnt1-Cre lineage tracing, we observed that YFP-positive NCCs at E10.5 had colonized the OFT and were present even within the most proximal segment of the OFT ( Figure 9A ). We then used the Tie2-Cre Rosa Yfp reporter to identify endoMT-derived cells by their YFP expression in the absence of PECAM ( Figure 3A ). This analysis revealed that Tie2-Cre targeted the OFT endothelium at E10.5 ( Figure 9B ), but only few YFP-positive, PECAM-negative single cells were present in the endocardial cushions ( Figure 9B ). In contrast, E12.5 OFTs contained many single cells that were YFP positive, but lacked PECAM ( Figure 9C ), demonstrating that they had arisen through endoMT. EndoMT therefore begins in the OFT at E10.5, when cardiac NCCs have already populated the entire length of the OFT. Moreover, the onset of endoMT correlates with a time when cardiac NCC began to express Sema3c in the OFT (see above, Figure 5A ).
SEMA3C signals through NRP1 to induce endoMT of OFT endothelium in vitro.
To investigate whether SEMA3C induces endoMT in the OFT in an NRP1-dependent manner, we used an established in vitro assay in which endoMT from explanted OFT tissue is measured as F-actin-positive cellular outgrowth (17, 40, 41) . Accordingly, we found that explants of Tie2-Cre Rosa Yfp OFTs at E10.5, when endoMT just begins ( Figure 9B ), gave rise to F-actin-positive outgrowth cells, most of which were YFP positive, but PECAM nega- ; P < 0.05). Taken together, these observations show that endothelial NRP1 is required for normal levels of endoMT in the developing mouse OFT in vivo.
Discussion
Even though the importance of NRP1 for OFT remodeling and therefore cardiovascular function has been recognized for more than a decade (11), its mechanism of action was not previously understood. A widely accepted hypothesis postulated that NRP1 contributes to OFT remodeling in a dual fashion: first, by enabling the SEMA3C-mediated attraction of NRP1-expressing cardiac NCCs into the OFT, and second, by acting as a VEGF-A receptor in NRP1-expressing OFT endothelium to induce an unidentified endothelial function. By taking advantage of a hitherto unavailable repertoire of tissue-specific and ligand-selective Nrp1 mouse mutants and analyzing them through in vivo and in vitro approaches, we have now overhauled the prior working model and defined roles for NRP1 in OFT septation. First, we found that neither NRP1 nor NRP2 is required to guide cardiac NCCs into the mouse OFT. Second, we demonstrated that endothelial NRP1 is not required as a receptor for VEGF-A during OFT remodeling, but that this process instead relies on SEMA3C signaling through NRP1 in OFT ECs. Third, we identified a hitherto unrecognized role for NCCderived SEMA3C and endothelial NRP1 in promoting endoMT in the OFT and therefore the generation of mesenchymal cells for the endocardial cushions. Finally, we found that SEMA3C signalon Nrp1-null and control OFTs at E10.5, when endoMT is initiated ( Figure 9B ). This experiment suggested reduced Slug expression in Nrp1-null mice compared with control littermates ( Figure 10A ). Quantitative real-time RT-PCR (qRT-PCR) analysis of E10.5 OFT tissue confirmed that Slug was significantly reduced in mutants compared with controls ( Figure 10B ; Slug mRNA levels relative to control and normalized to Gapdh expression: 1% ± 0.09% Nrp1 ; P < 0.05). We also performed immunostaining of E11.25 serial OFT sections for PECAM and a previously validated antibody for SLUG (44) . WT OFTs contained many SLUG-positive cells, particularly in areas close to the endothelium, but also surrounding the areas where the paired NCC columns reside at this stage ( Figure 10D ). Staining appeared to be mostly nuclear, in keeping with SLUG's role as a transcription factor and in agreement with prior reports (44) (45) (46) . In contrast, Nrp1-null OFTs contained fewer SLUGpositive single cells immediately adjacent to the OFT endothelium ( Figure 10D) , consistent with the hypothesis that NRP1 promotes endoMT in the OFT. Immunolabeling of E11.25 OFTs also revealed fewer SLUG-positive single cells near OFT endothelium in Wnt1-Cre Sema3c fl/fl mutant compared with control OFTs (Supplemental Figure 3) .
Intriguingly, SLUG labeling of Nrp1-null OFTs suggested that many SLUG-positive cells were retained within the OFT endothelium ( Figure 10D ). This observation raised the possibility that defective endoMT induction at E10.5 caused endothelial retention of cells that are normally destined for endoMT. Moreover, SLUG staining, rather than being nuclear, appeared predominantly cytoplasmic in the OFT endothelium of Nrp1-null mutants ( Figure 10D) . A similar staining pattern was previously observed in cells with impaired SLUG phosphorylation (47) , raising the possibility that cytoplasmic SLUG staining in Nrp1-null OFTs reflects dysregulated signaling. mutants had normal cardiac NCC migration into the OFT disagrees with prior studies in chick, in which siRNA-mediated NRP1 targeting impaired this process (14) . This discrepancy might be due to species differences in cardiac NCC behavior. In support of this idea, the misregulation of SDF1 or its receptor CXCR4 also perturbs cardiac NCC migration in chick (49) , whereas the corresponding mouse mutants display only mild anomalies (50, 51) . Alternatively, the siRNA-mediated knockdown technology used for the chick studies may have sensitized NCCs to developmental defects.
In contrast to Wnt1-Cre Nrp1 fl/fl Nrp2 -/-mice, Tie2-Cre Nrp1 fl/-mutants fully recapitulated the OFT defects of full Nrp1-null ing through NRP1 is required for the fusion of the bilateral cardiac NCC columns in the central OFT to enable the formation and myocardialization of the septal bridge that separates the emerging aortic and pulmonary trunks. Genetic knockout studies have previously implicated SEMA3C as a critical factor for OFT septation (8) . Because SEMA3C binds both NRPs with similar affinity (27, 48) , the occurrence of CAT in Nrp1
Sema/Sema Nrp2 -/-mice was thought to indicate that SEMA3C acts on cells that express both NRPs. In particular, it was suggested that these SEMA3C-dependent cells are cardiac NCCs 
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endothelial-specific or full Nrp1-null mutation, even though NRP2 can rescue the Nrp1 Sema mutation (11, 13) . NRP1 signaling in OFT endothelium appears to require a signal-transducing coreceptor because mice lacking the cytoplasmic tail of NRP1 are viable and should therefore lack OFT defects (54). This endothelial NRP1 coreceptor is likely PLXND1, because (a) both NRP1 and NRP2 form complexes with PLXND1, (b) PLXND1 enhances SEMA3C binding to NRP-expressing Cos7 cells, and (c) Plxnd1-null mice have OFT defects similar to those of NRP1 and SEMA3C knockouts (24) . Moreover, the endothelial PLXND1 deletion, similar to the endothelial NRP1 deletion, recapitulates the OFT defects of constitutive Plxnd1-null mutants, demonstrating that the essential function of the NRP1/PLXND1 receptor complex occurs in OFT endothelium rather than in another cell type such as cardiac NCCs (55) .
We also tested the prior hypothesis that NRP1 acts as a VEGF-A receptor in OFT endothelium (13) . This hypothesis was an extrapolation of findings in ECs in vitro, in which NRP1 forms a complex with VEGFR2 to enhance VEGF-A signaling through VEGFR2 (56).
mice. This finding suggests that all major NRP1-dependent steps during OFT remodeling are orchestrated by endothelial NRP1, with no obvious NRP1-dependent roles for cardiac NCCs (and perhaps a minor role of NRP1 in SMA-positive cells during septal bridge myocardialization, which we have not investigated). Given the essential role of SEMA3C signaling through endothelial NRP1 in OFT septation, it is not immediately obvious why NRP2 is able to compensate for loss of semaphorin binding to NRP1, as observed in Nrp1
Sema/Sema mice (13) . One possibility is that NRP2 and NRP1 form a heterodimer, in which both NRPs function redundantly as SEMA3C receptors. In agreement, heterodimer formation has been demonstrated in Cos7 cells in vitro, where NRP1 and NRP2 preassemble in a ligand-independent fashion (27, 48, 52) . In a heterodimeric complex, NRP2 may be sufficient to bind SEMA3C, even if the semaphorin-binding domain of NRP1 is disrupted; however, the remainder of the NRP1 receptor is likely indispensable for downstream signaling. In support of this model, Nrp2
-/-mutants do not display defects in OFT remodeling (53) and NRP2 is not sufficient to substitute for the -/-OFTs (n = 3 each) were cultured for 72 hours in 1% FBS with or without 400 ng/ml SEMA3C and labeled for F-actin and DAPI. The number of F-actin-positive emigrated cells was quantitated. Mean ± SD. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001, 2-tailed, unpaired Student's t test. Scale bars: 100 μm (A and B) ; 200 μm (C-I).
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Our finding that cardiac NCCs provide an essential source of Sema3c for OFT septation disagrees with the prior hypothesis that SEMA3C attracts NCCs into the OFT, but supports a role for SEMA3C as a signal secreted by NCCs. In agreement, the NCCspecific deletion of Gata6, which drives SEMA3C expression, also causes OFT defects (59) . Even though SEMA3C was not required to attract cardiac NCCs into the OFT, and loss of SEMA3C receptors from cardiac NCCs did not impair OFT septation, these cells were indirectly affected by defective endothelial SEMA3C/NRP1 signaling. Thus, cardiac NCCs were abnormally placed in paired columns in the lateral parts of the endocardial cushions of E12.5 Nrp1-null mutants in positions where NCCs normally reside at earlier stages. Moreover, mutants lacking endothelial NRP1 or NCCderived SEMA3C had similar defects. These observations suggest However, the importance of this pathway in vivo has so far only been demonstrated for arteriogenesis (57) . In contrast, the results presented here show that mice lacking VEGF-A binding to NRP1 have normal OFT remodeling, even in the absence of NRP2. This finding was particularly unexpected because Vegfa 120/120 mice lacking the NRP1-binding VEGF164 isoform have defective OFT septation, although with only 50% penetrance (9). Our observations therefore imply that the phenotype of Vegfa 120/120 mice is not linked to NRP1's ability to bind VEGF-A. Instead, lack of extracellular matrix retention of VEGF120, known to be responsible for vascular-patterning defects in other tissues (58) , may contribute to OFT defects in Vegfa 120/120 mice by reducing endothelial VEGFR2 signaling. Importantly, our results show that VEGF-A and SEMA3C are required for distinct aspects of OFT development. bound into noninvasive epithelial or endothelial monolayers into migratory single cells. Some endoMT was still evident in the OFT of mice lacking SEMA3C signaling through NRP1, presumably because several complementary pathways contribute to this process. Thus, the SHF is a source for other molecules required for endoMT in the OFT, such as FGF8 (70, 71) and BMP4 (17, 72, 73) . Furthermore, loss of Notch signaling in the SHF reduces FGF8 and BMP4 secretion, which is accompanied by impaired cardiac NCC immigration, reduced endoMT, and a failure of OFT septation (25) . These prior studies concluded that SHF-derived mesoderm communicates with both cardiac NCCs and ECs to induce OFT septation. Our study has revealed an additional mechanism by which cardiac NCCs instruct the endothelium to help initiate endoMT and has also showed that endothelial signaling then instructs cardiac NCC relocalization for OFT septation. Accordingly, SEMA3C is one key member in a class of diverse molecules required for physiological endoMT during heart development. Further work will be necessary to determine how SEMA3C signaling through endothelial NRP1 interacts with or complements Notch, FGF8, and BMP4 signaling in the OFT. Interestingly, impaired cardiac NCC migration precedes defective endoMT observed within the OFT cushions of Notch, FGF8, and BMP4 mutants, reinforcing the idea that NCCs are causally linked to endoMT.
In summary, we have replaced prior hypotheses of NRP function in OFT remodeling with a substantially revised model, which embraces the complexity of developmental events that ensure proper OFT septation and involves multiple signaling events between the contributing cell lineages. Unraveling these complex interactions at the molecular and cellular level in mouse models will inform our interpretation of human genetic data obtained from patients with congenital heart defects, where a heterozygous single gene mutation is rarely found to be causative. In support of the idea that defective NRP1 signaling contributes to human congenital heart disease, a recent GWAS study uncovered a nucleotide polymorphism in the NRP1 sequence that was associated with tetralogy of Fallot, while another study identified a homozygous splice mutation that ablates NRP1 exon 3 in a patient with CAT and is predicted to disrupt the semaphorin-binding domain of NRP1 (74, 75) .
Methods
Mouse strains. Mice were paired in the evening, and the morning on which a vaginal plug was observed was defined as E0.5. Mice carrying Nrp1-or Nrp2-null alleles and Vegfa Lacz reporter mice were maintained on a CD1 background (21, 76, 77 Homologous recombination was performed in JM8A3.N1 embryonic stem cells, and positive clones were injected into C57BL/6 blastocysts. Chimeric mice were crossed to C57BL/6 mice to identify that the convergence of the lateral NCC streams in the central OFT to enable septal bridge formation had failed in mutants with defective SEMA3C/NRP1 signaling in OFT endothelium and agree with the finding that NRP1-expressing primary ECs can respond to SEMA3C (60, 61) . Moreover, it has been shown that SEMA3C binds to NRP1 in diverse cell types in vitro (24) and to NRP1-expressing vessels in vivo (62) . Given that the only known SEMA3C receptors are NRP1 and NRP2, and in light of our expression studies, in vitro experiments, and genetic analyses, we conclude that NRP1 acts as an essential endothelial SEMA3C receptor during OFT septation, with a backup function for NRP2. The incomplete penetrance of distal, as opposed to proximal, OFT septation defects in Wnt1-Cre Sema3c fl/fl and Nrp1
Sema/Sema
Nrp2 -/-mice may be due to a number of factors. Variability in our analyses may be secondary to inefficient Cre-mediated targeting of the conditional Sema3c-null allele, whereas the Nrp1 Sema allele may encode a protein with residual ligand-binding activity. Additionally, incomplete penetrance may be secondary to stochastic or genetic background effects. In agreement, previous reports of constitutive Sema3c-null mutants described partially penetrant (75%) and partial (i.e., incomplete) OFT septation defects, with postnatal mortality of Sema3c-null mice being 50% lower on a C57BL/6 than on a CD1 background (8) . Alternatively, Nrp1-null and Tie2-Cre Nrp1 fl/-mutants with usually complete CAT may differ from Nrp1
Sema/Sema Nrp2 -/-mice with frequent partial CAT due to the existence of additional NRP1-dependent, but SEMA3C-independent pathways that contribute to OFT remodeling. Because Nrp1
Vegfa/Vegfa mutants lacked OFT defects, an attractive possibility is a role for NRP1 in conveying signals provided by extracellular matrix molecules such as fibronectin, which can induce EC motility and cytoskeletal remodeling in an NRP1-dependent, but SEMA3-and VEGF-A-independent, pathway via the ABL1 and ABL2 kinases (63) . In support of this idea, fibronectin is abundant in the remodeling OFT (64) and integrins have been implicated in OFT remodeling (26, 65) .
Previous studies as well as our endothelial lineage tracing have shown that endoMT contributes significantly to endocardial cushion development in the proximal OFT (66) . Moreover, mice with reduced BMP signaling have smaller endocardial cushions and lack proximal OFT septation (67), similar to Wnt1-Cre Sema3c fl/fl mutants. To address whether SEMA3C signaling through NRP1 promotes endoMT in the OFT, we used an explant assay that suggested that SEMA3C was sufficient to induce endoMT, that NCC-derived SEMA3C and NRP1 were both required for normal endoMT in this experimental setting, and that loss of endoMT in NRP1-deficient explants could not be rescued by exogenous SEMA3C. Furthermore, expression of Slug, a known marker of endoMT (42, 43) , was reduced in the OFT of mice lacking SEMA3C or NRP1 compared with littermate controls just before the onset of endoMT. Finally, correlating with impaired Slug expression, mice lacking endothelial NRP1 showed a reduced contribution of endoMT-derived cells to the endocardial cushions of the proximal OFT. Interestingly, the enhanced expression of SEMA3C (68) or NRP1 (69) in cancer cells increases tumor invasiveness, a process in which tumor cells acquire mesenchymal properties analogous to endoMT. Thus, SEMA3C-dependent NRP1 signaling may represent a conserved mechanism that promotes the conversion of cells
The Journal of Clinical Investigation R e s e a R c h a R t i c l e 2 6 7 4 jci.org Volume 125 Number 7 July 2015 tems) using SYBR Green PCR Master Mix (Applied Biosystems) and 0.45 μg of the following oligonucleotides (Sigma-Aldrich): Gapdh, 5′-TGCGACTTCAACAGCAACTC-3′ and 5′-CTTGCTCAGTGTCCTT-GCTG-3′, amplicon 200 bps; Nrp1, 5′-CCATTATAGACAGCAC-CATCC-3′ and 5′-AAGTTGCCATCTCCTGTATG-3′, amplicon 178 bps; Slug, 5′-TTCAACGCCTCCAAGAAGCC-3′ and 5′-GGG-TAAAGGAGAGTGGAGTGG-3′, amplicon 183 bps; and Sema3c 5′-CCAGTGTGCACCTACCTGAA-3′ and 5′-TCGGGTTGAAAGAG-CATCGT-3′ amplicon 103 bps. For each gene, the reaction was run in triplicate, and for each primer pair, a no-template control was included. Data were collected using Sequence Detector Software (SDS version 2.2; Applied Biosystems) and expression levels extrapolated using DART-PCR software (83) and normalized to Gapdh expression. In some experiments, qRT-PCR products were visualized by agarose (BDH Electran) gel electrophoresis.
Statistics. For each analysis, we examined at least 3 independent samples per experimental group; for qRT-PCR analysis, the average of triplicate reactions was used as the value of that sample. Results are expressed as mean ± SD relative to the specified controls. For all statistical analyses, we used a 2-tailed, unpaired Student's t test. P values of less than 0.05 were considered significant.
Study approval. Animal experiments were conducted with ethical approval from the Animal Welfare and Ethical Review Body of the UCL Institute of Ophthalmology and carried out under United Kingdom Home Office licence 70/7126.
